These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12060631)

  • 21. Clinical value of loss of heterozygosity in serum microsatellite DNA of patients with gastrointestinal stromal tumors.
    Schurr PG; Oikonomou D; Kaifi JT; Merkert P; Wolter S; Kleinhans H; Reichelt U; Mann O; Gawad KA; Strate T; Yekebas EF; Izbicki JR
    J Clin Gastroenterol; 2009 Jan; 43(1):27-35. PubMed ID: 18469721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of carbonic anhydrase-9 gene expression in peripheral blood cells predicts risk of disease recurrence in patients with renal cortical tumors.
    Gilbert SM; Whitson JM; Mansukhani M; Buttyan R; Benson MC; Olsson CA; Sawczuk IS; McKiernan JM
    Urology; 2006 May; 67(5):942-5. PubMed ID: 16698354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microvascular tumor invasion: prognostic significance in low-stage renal cell carcinoma.
    Madbouly K; Al-Qahtani SM; Ghazwani Y; Al-Shaibani S; Mansi MK
    Urology; 2007 Apr; 69(4):670-4. PubMed ID: 17445649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
    Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
    J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
    Ishimura T; Sakai I; Hara I; Eto H; Miyake H
    Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder.
    Turyn J; Matuszewski M; Schlichtholz B
    Oncol Rep; 2006 Jan; 15(1):259-65. PubMed ID: 16328066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
    Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
    Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of platelet count in patients with renal cell carcinoma.
    Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
    Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage.
    Singh KJ; Singh SK; Suri A; Vijjan V; Goswami AK; Khullar M
    Indian J Cancer; 2005; 42(4):197-200. PubMed ID: 16391438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis.
    Sozzi G; Musso K; Ratcliffe C; Goldstraw P; Pierotti MA; Pastorino U
    Clin Cancer Res; 1999 Oct; 5(10):2689-92. PubMed ID: 10537330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of urinary microsatellite analysis in the diagnosis of renal cancer].
    Fernandez F; Schneider A; Gaub MP; Lindner V; Oudet P; Lang H; Saussine C; Jacqmin D
    Prog Urol; 2006 Sep; 16(4):429-34. PubMed ID: 17069034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor cell proliferation and microsatellite alterations in human ameloblastoma.
    Migaldi M; Sartori G; Rossi G; Cittadini A; Sgambato A
    Oral Oncol; 2008 Jan; 44(1):50-60. PubMed ID: 17307020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.
    Rouprêt M; Hupertan V; Yates DR; Comperat E; Catto JW; Meuth M; Lackmichi A; Ricci S; Lacave R; Gattegno B; Richard F; Hamdy FC; Cussenot O
    BJU Int; 2008 Jun; 101(11):1448-53. PubMed ID: 18325051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma.
    Kaku H; Ito S; Ebara S; Ouchida M; Nasu Y; Tsushima T; Kumon H; Shimizu K
    Urology; 2004 Jul; 64(1):176-81. PubMed ID: 15245966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The detection of oesophageal adenocarcinoma by serum microsatellite analysis.
    Eisenberger CF; Stoecklein NH; Jazra S; Hosch SB; Peiper M; Scheunemann P; Am Esch JS; Knoefel WT
    Eur J Surg Oncol; 2006 Nov; 32(9):954-60. PubMed ID: 16584865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.
    Thompson RH; Boorjian SA; Lohse CM; Leibovich BC; Kwon ED; Cheville JC; Blute ML
    J Urol; 2008 Feb; 179(2):468-71; discussion 472-3. PubMed ID: 18076931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular signature for urothelial carcinoma of the upper urinary tract.
    Ho CL; Tzai TS; Chen JC; Tsai HW; Cheng HL; Eisenberger CF; Chow NH
    J Urol; 2008 Mar; 179(3):1155-9. PubMed ID: 18206169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.